Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Pyxis Oncology
PYXS
$168M
| $202K | ﹤0.01% |
129,761
| – | – |
|
3327
OptimizeRx
OPRX
$114M
| $202K | ﹤0.01% |
41,552
-6,885
| -14% | -$38.5K |
|
3328
Veru
VERU
$36M
| $202K | ﹤0.01% |
31,025
| – | – |
|
3329
NLI Holdings
NL
$281M
| $200K | ﹤0.01% |
25,715
| – | – |
|
3330
Palladyne AI
PDYN
$247M
| $198K | ﹤0.01% |
16,115
| – | – |
|
3331
Roadzen
RDZN
$97.2M
| $198K | ﹤0.01% |
90,672
+55,759
| +160% | +$68.9K |
|
3332
Commercial Vehicle Group
CVGI
$154M
| $197K | ﹤0.01% |
79,252
-13,417
| -14% | -$35.8K |
|
3333
Nautilus Biotechnolgy
NAUT
$124M
| $194K | ﹤0.01% |
115,231
-22,256
| -16% | -$53.2K |
|
3334
VirTra
VTSI
$34.9M
| $192K | ﹤0.01% |
28,501
| – | – |
|
3335
Vuzix
VUZI
$194M
| $192K | ﹤0.01% |
+48,683
| New | +$99.8K |
|
3336
Telomir Pharmaceuticals
TELO
$83.2M
| $191K | ﹤0.01% |
46,406
+35,556
| +328% | +$168K |
|
3337
DLH Holdings
DLHC
$70.7M
| $191K | ﹤0.01% |
23,788
| – | – |
|
3338
Greenwich LifeSciences
GLSI
$198M
| $185K | ﹤0.01% |
16,455
| – | – |
|
|
AISP
3339
Airship AI Holdings
AISP
$60.3M
| $185K | ﹤0.01% |
29,507
| – | – |
|
3340
PepGen
PEPG
$122M
| $183K | ﹤0.01% |
48,351
| – | – |
|
|
CMRX
3341
DELISTED
Chimerix, Inc.
CMRX
| $183K | ﹤0.01% |
+52,657
| New | +$74.3K |
|
3342
The ONE Group
STKS
$56.2M
| $181K | ﹤0.01% |
62,260
| – | – |
|
3343
Skye Bioscience
SKYE
$20M
| $176K | ﹤0.01% |
62,363
+10,707
| +21% | +$44.7K |
|
3344
Eton Pharmaceutcials
ETON
$1.27B
| $176K | ﹤0.01% |
13,239
| – | – |
|
3345
Kopin
KOPN
$652M
| $171K | ﹤0.01% |
+125,892
| New | +$121K |
|
3346
Strawberry Fields REIT
STRW
$191M
| $170K | ﹤0.01% |
16,118
-56
| -0.3% | -$650 |
|
3347
Fractyl Health
GUTS
$109M
| $166K | ﹤0.01% |
80,664
| – | – |
|
3348
INmune Bio
INMB
$46.5M
| $162K | ﹤0.01% |
34,666
+676
| +2% | +$3.52K |
|
|
EARN
3349
Ellington Residential Mortgage REIT
EARN
$162M
| $162K | ﹤0.01% |
24,423
| – | – |
|
|
SWKH
3350
DELISTED
SWK Holdings
SWKH
| $162K | ﹤0.01% |
12,856
| – | – |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.